These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 10332980

  • 21. Therapy for the maintenance of remission in sixty-five patients with generalized Wegener's granulomatosis. Methotrexate versus trimethoprim/sulfamethoxazole.
    de Groot K, Reinhold-Keller E, Tatsis E, Paulsen J, Heller M, Nölle B, Gross WL.
    Arthritis Rheum; 1996 Dec; 39(12):2052-61. PubMed ID: 8961911
    [Abstract] [Full Text] [Related]

  • 22. Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double-blind, placebo-controlled trial.
    O'Dell JR, Leff R, Paulsen G, Haire C, Mallek J, Eckhoff PJ, Fernandez A, Blakely K, Wees S, Stoner J, Hadley S, Felt J, Palmer W, Waytz P, Churchill M, Klassen L, Moore G.
    Arthritis Rheum; 2002 May; 46(5):1164-70. PubMed ID: 12115219
    [Abstract] [Full Text] [Related]

  • 23. Meningeal involvement in Wegener's granulomatosis.
    Al Dhanhani A, Macaulay R, Maloney B, Hanly JG.
    J Rheumatol; 2006 Feb; 33(2):364-7. PubMed ID: 16465672
    [Abstract] [Full Text] [Related]

  • 24. Treatment of early seropositive rheumatoid arthritis: doxycycline plus methotrexate versus methotrexate alone.
    O'Dell JR, Elliott JR, Mallek JA, Mikuls TR, Weaver CA, Glickstein S, Blakely KM, Hausch R, Leff RD.
    Arthritis Rheum; 2006 Feb; 54(2):621-7. PubMed ID: 16447240
    [Abstract] [Full Text] [Related]

  • 25. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated.
    Ehrich JH, Geerlings C, Zivicnjak M, Franke D, Geerlings H, Gellermann J.
    Nephrol Dial Transplant; 2007 Aug; 22(8):2183-93. PubMed ID: 17504846
    [Abstract] [Full Text] [Related]

  • 26. [Wegener's granulomatosis in ENT: clinical presentation, diagnosis and therapy].
    Tesche S, Münscher A, Metternich FU.
    Laryngorhinootologie; 2007 Nov; 86(11):775-9. PubMed ID: 17724622
    [Abstract] [Full Text] [Related]

  • 27. Crescentic glomerulonephritis in Wegener's granulomatosis: morphology, therapy, outcome.
    Grotz W, Wanner C, Keller E, Böhler J, Peter HH, Rohrbach R, Schollmeyer P.
    Clin Nephrol; 1991 Jun; 35(6):243-51. PubMed ID: 1873937
    [Abstract] [Full Text] [Related]

  • 28. Wegener's granulomatosis: survey of 701 patients in North America. Changes in outcome in the 1990s.
    Abdou NI, Kullman GJ, Hoffman GS, Sharp GC, Specks U, McDonald T, Garrity J, Goeken JA, Allen NB.
    J Rheumatol; 2002 Feb; 29(2):309-16. PubMed ID: 11838848
    [Abstract] [Full Text] [Related]

  • 29. Treatment of refractory myositis: a randomized crossover study of two new cytotoxic regimens.
    Villalba L, Hicks JE, Adams EM, Sherman JB, Gourley MF, Leff RL, Thornton BC, Burgess SH, Plotz PH, Miller FW.
    Arthritis Rheum; 1998 Mar; 41(3):392-9. PubMed ID: 9506565
    [Abstract] [Full Text] [Related]

  • 30. How aggressive should initial therapy for rheumatoid arthritis be? Factors associated with response to 'non-aggressive' DMARD treatment and perspective from a 2-yr open label trial.
    Matteson EL, Weyand CM, Fulbright JW, Christianson TJ, McClelland RL, Goronzy JJ.
    Rheumatology (Oxford); 2004 May; 43(5):619-25. PubMed ID: 14983105
    [Abstract] [Full Text] [Related]

  • 31. Early diagnosis and stage-adapted treatment of Wegener's granulomatosis.
    Cadoni G, Agostino S, Campobasso E, Vulpiani P, Manna R, Galli J.
    J Laryngol Otol; 2003 Mar; 117(3):208-11. PubMed ID: 12648379
    [Abstract] [Full Text] [Related]

  • 32. Midline granuloma and Wegener's granulomatosis: clinical & therapeutic considerations.
    Schechter SL, Bole GG, Walker SE.
    J Rheumatol; 1976 Sep; 3(3):241-50. PubMed ID: 789880
    [Abstract] [Full Text] [Related]

  • 33. Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET).
    Seo P, Min YI, Holbrook JT, Hoffman GS, Merkel PA, Spiera R, Davis JC, Ytterberg SR, St Clair EW, McCune WJ, Specks U, Allen NB, Luqmani RA, Stone JH, WGET Research Group.
    Arthritis Rheum; 2005 Jul; 52(7):2168-78. PubMed ID: 15986348
    [Abstract] [Full Text] [Related]

  • 34. Methotrexate therapy in refractory pediatric onset systemic lupus erythematosus.
    Ravelli A, Ballardini G, Viola S, Villa I, Ruperto N, Martini A.
    J Rheumatol; 1998 Mar; 25(3):572-5. PubMed ID: 9517783
    [Abstract] [Full Text] [Related]

  • 35. [Acute myocardial infarction secondary to Wegener's granulomatosis].
    Fuertes Beneitez J, García-Iglesias F, Gallego García de Vinuesa P, García-Tobaruela A, Gómez-Guindal JA, Lavilla Uriol P, Gil Aguado A, Sobrino Daza JA, Martín-Jadraque L.
    Rev Esp Cardiol; 1998 Apr; 51(4):336-9. PubMed ID: 9608807
    [Abstract] [Full Text] [Related]

  • 36. Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's granulomatosis etanercept trial.
    Stone JH, Wegener's Granulomatosis Etanercept Trial Research Group.
    Arthritis Rheum; 2003 Aug; 48(8):2299-309. PubMed ID: 12905485
    [Abstract] [Full Text] [Related]

  • 37. Substitution of methotrexate for cyclophosphamide in Wegener granulomatosis: a 12-year single-practice experience.
    Villa-Forte A, Clark TM, Gomes M, Carey J, Mascha E, Karafa MT, Roberson G, Langford CA, Hoffman GS.
    Medicine (Baltimore); 2007 Sep; 86(5):269-277. PubMed ID: 17873756
    [Abstract] [Full Text] [Related]

  • 38. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial.
    Lambert CM, Sandhu S, Lochhead A, Hurst NP, McRorie E, Dhillon V.
    Arthritis Rheum; 2004 Feb; 50(2):364-71. PubMed ID: 14872477
    [Abstract] [Full Text] [Related]

  • 39. Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients.
    Wenzel J, Brähler S, Bauer R, Bieber T, Tüting T.
    Br J Dermatol; 2005 Jul; 153(1):157-62. PubMed ID: 16029342
    [Abstract] [Full Text] [Related]

  • 40. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB.
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.